Scalable hiPSC Platform for ASO Efficacy and Toxicity Screening
hiPSC-Derived Neurons and Microglia: In Vitro Neuroinflammation
MCL1 Inhibitor Cardiotoxicity Assessment Using iPSC-Derived Models
Research highlights: Targeted Protein Degradation in Tauopathies
Case Study: Development of a human iPSC-derived ALS model
-1.png)
The status of drug discovery and development for Parkinson's disease
Subscribe to our newsletter
Stay up to date on iPSC innovations, events and news.
